Literature DB >> 35581355

Opportunities and challenges for the use of common controls in sequencing studies.

Genevieve L Wojcik1, Jessica Murphy2,3, Jacob L Edelson4, Christopher R Gignoux2,5,6, Alexander G Ioannidis7,8, Alisa Manning9,10, Manuel A Rivas4, Steven Buyske11, Audrey E Hendricks12,13,14,15.   

Abstract

Genome-wide association studies using large-scale genome and exome sequencing data have become increasingly valuable in identifying associations between genetic variants and disease, transforming basic research and translational medicine. However, this progress has not been equally shared across all people and conditions, in part due to limited resources. Leveraging publicly available sequencing data as external common controls, rather than sequencing new controls for every study, can better allocate resources by augmenting control sample sizes or providing controls where none existed. However, common control studies must be carefully planned and executed as even small differences in sample ascertainment and processing can result in substantial bias. Here, we discuss challenges and opportunities for the robust use of common controls in high-throughput sequencing studies, including study design, quality control and statistical approaches. Thoughtful generation and use of large and valuable genetic sequencing data sets will enable investigation of a broader and more representative set of conditions, environments and genetic ancestries than otherwise possible.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35581355     DOI: 10.1038/s41576-022-00487-4

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   59.581


  134 in total

1.  How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum.

Authors:  Siddharth Banka; Ratna Veeramachaneni; William Reardon; Emma Howard; Sancha Bunstone; Nicola Ragge; Michael J Parker; Yanick J Crow; Bronwyn Kerr; Helen Kingston; Kay Metcalfe; Kate Chandler; Alex Magee; Fiona Stewart; Vivienne P M McConnell; Deirdre E Donnelly; Siren Berland; Gunnar Houge; Jenny E Morton; Christine Oley; Nicole Revencu; Soo-Mi Park; Sally J Davies; Andrew E Fry; Sally Ann Lynch; Harinder Gill; Susann Schweiger; Wayne W K Lam; John Tolmie; Shehla N Mohammed; Emma Hobson; Audrey Smith; Moira Blyth; Christopher Bennett; Pradeep C Vasudevan; Sixto García-Miñaúr; Alex Henderson; Judith Goodship; Michael J Wright; Richard Fisher; Richard Gibbons; Susan M Price; Deepthi C de Silva; I Karen Temple; Amanda L Collins; Katherine Lachlan; Frances Elmslie; Meriel McEntagart; Bruce Castle; Jill Clayton-Smith; Graeme C Black; Dian Donnai
Journal:  Eur J Hum Genet       Date:  2011-11-30       Impact factor: 4.246

2.  Exome sequencing makes medical genomics a reality.

Authors:  Leslie G Biesecker
Journal:  Nat Genet       Date:  2010-01       Impact factor: 38.330

3.  ClinGen--the Clinical Genome Resource.

Authors:  Heidi L Rehm; Jonathan S Berg; Lisa D Brooks; Carlos D Bustamante; James P Evans; Melissa J Landrum; David H Ledbetter; Donna R Maglott; Christa Lese Martin; Robert L Nussbaum; Sharon E Plon; Erin M Ramos; Stephen T Sherry; Michael S Watson
Journal:  N Engl J Med       Date:  2015-05-27       Impact factor: 91.245

4.  Rare variant contribution to human disease in 281,104 UK Biobank exomes.

Authors:  Quanli Wang; Ryan S Dhindsa; Keren Carss; Andrew R Harper; Abhishek Nag; Ioanna Tachmazidou; Dimitrios Vitsios; Sri V V Deevi; Alex Mackay; Daniel Muthas; Michael Hühn; Susan Monkley; Henric Olsson; Sebastian Wasilewski; Katherine R Smith; Ruth March; Adam Platt; Carolina Haefliger; Slavé Petrovski
Journal:  Nature       Date:  2021-08-10       Impact factor: 69.504

5.  Exome sequencing identifies the cause of a mendelian disorder.

Authors:  Sarah B Ng; Kati J Buckingham; Choli Lee; Abigail W Bigham; Holly K Tabor; Karin M Dent; Chad D Huff; Paul T Shannon; Ethylin Wang Jabs; Deborah A Nickerson; Jay Shendure; Michael J Bamshad
Journal:  Nat Genet       Date:  2009-11-13       Impact factor: 38.330

Review 6.  Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank.

Authors:  Joseph D Szustakowski; Suganthi Balasubramanian; Erika Kvikstad; Shareef Khalid; Paola G Bronson; Ariella Sasson; Emily Wong; Daren Liu; J Wade Davis; Carolina Haefliger; A Katrina Loomis; Rajesh Mikkilineni; Hyun Ji Noh; Samir Wadhawan; Xiaodong Bai; Alicia Hawes; Olga Krasheninina; Ricardo Ulloa; Alex E Lopez; Erin N Smith; Jeffrey F Waring; Christopher D Whelan; Ellen A Tsai; John D Overton; William J Salerno; Howard Jacob; Sandor Szalma; Heiko Runz; Gregory Hinkle; Paul Nioi; Slavé Petrovski; Melissa R Miller; Aris Baras; Lyndon J Mitnaul; Jeffrey G Reid
Journal:  Nat Genet       Date:  2021-06-28       Impact factor: 38.330

7.  Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity.

Authors:  Parsa Akbari; Ankit Gilani; Olukayode Sosina; Roberto Tapia-Conyer; Michal L Schwartzman; Aris Baras; Manuel A R Ferreira; Luca A Lotta; Jack A Kosmicki; Lori Khrimian; Yi-Ya Fang; Trikaldarshi Persaud; Victor Garcia; Dylan Sun; Alexander Li; Joelle Mbatchou; Adam E Locke; Christian Benner; Niek Verweij; Nan Lin; Sakib Hossain; Kevin Agostinucci; Jonathan V Pascale; Ercument Dirice; Michael Dunn; William E Kraus; Svati H Shah; Yii-Der I Chen; Jerome I Rotter; Daniel J Rader; Olle Melander; Christopher D Still; Tooraj Mirshahi; David J Carey; Jaime Berumen-Campos; Pablo Kuri-Morales; Jesus Alegre-Díaz; Jason M Torres; Jonathan R Emberson; Rory Collins; Suganthi Balasubramanian; Alicia Hawes; Marcus Jones; Brian Zambrowicz; Andrew J Murphy; Charles Paulding; Giovanni Coppola; John D Overton; Jeffrey G Reid; Alan R Shuldiner; Michael Cantor; Hyun M Kang; Goncalo R Abecasis; Katia Karalis; Aris N Economides; Jonathan Marchini; George D Yancopoulos; Mark W Sleeman; Judith Altarejos; Giusy Della Gatta
Journal:  Science       Date:  2021-07-02       Impact factor: 47.728

8.  The Human Genome Project changed everything.

Authors:  Richard A Gibbs
Journal:  Nat Rev Genet       Date:  2020-10       Impact factor: 53.242

9.  Evaluating drug targets through human loss-of-function genetic variation.

Authors:  Eric Vallabh Minikel; Konrad J Karczewski; Hilary C Martin; Beryl B Cummings; Nicola Whiffin; Daniel Rhodes; Jessica Alföldi; Richard C Trembath; David A van Heel; Mark J Daly; Stuart L Schreiber; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 49.962

Review 10.  The road ahead in genetics and genomics.

Authors:  Amy L McGuire; Stacey Gabriel; Sarah A Tishkoff; Ambroise Wonkam; Aravinda Chakravarti; Eileen E M Furlong; Barbara Treutlein; Alexander Meissner; Howard Y Chang; Núria López-Bigas; Eran Segal; Jin-Soo Kim
Journal:  Nat Rev Genet       Date:  2020-08-24       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.